For Researchers
- Research
- Research Program
- Published Research Archive
- Current Published Research
- Research Activities
- Supported Studies
- How a Drug Comes to Market
FAAN Research Grant Program
FAAN is accepting new applications for the 2010 competitive research grant cycle! Our program focuses on the Epidemiology, Etiology, Treatment, and Prevention of Food Allergy and Anaphylaxis.
To apply, please go to https://proposalcentral.altum.com and follow the indications providing on how to submit a two-page “Letter of Intent.” The deadline for submission has been extended from the original date to June 21, 2010.
This grant program is open to investigators all over the world. Investigators in the United States must have an M.D. and/or Ph.D. Investigators outside the United States must have the equivalent. Competitive applicants have a proven track record of research experience.
One- to two-year grants are awarded in the range of $50,000-$150,000 annually.
For questions regarding research programs, eligibility, and policies, and terms and conditions, send an e-mail to FAAN’s director of research.
Research Grant Recipients
2009 Cycle
Stacie Jones, M.D.
Arkansas Children’s Hospital
Tree nut-specific immunotherapy for people who have multiple tree nut allergies
David Holdford, M.D.
Virginia Commonwealth University
Examination of the economic impact of food allergy and anaphylaxis in the U.S.
2008 Cycle
Carlos Camargo, M.D., Dr.P.H.
Massachusetts General Hospital
Prospective study of vitamin D in cord blood and risk of food allergy
Simon Hogan, Ph.D.
Cincinnati Children's Hospital Medical Center
Intestinal IL-9 and mast cells in food-induced anaphylaxis
Patrick Leung, Ph.D.
University of California-Davis
Mimotype vaccine against shrimp tropomyosin
Marc Rothenberg, M.D., Ph.D.
Cincinnati Children's Hospital Medical Center
The role of CREB binding protein (CBP) in eosinophilic esophagitis (EE)
Xiaoping Zhong, M.D., Ph.D.
Duke University Medical Center
Therapy for peanut-induced allergy and anaphylaxis
Daocheng Zhu, M.D., Ph.D.
Northwestern University - Evanston
Novel plant-human fusion proteins block peanut allergy
2007 Cycle
Kirsten Beyer, M.D.
Charité Universitätsmedizin Berlin
Primary prevention of hen’s egg allergy through early hen’s egg feeding
Mimi Tang, Ph.D.
Murdoch Childrens Research Institute
Probiotics and oral immunotherapy for the treatment of peanut allergy
Carla Bruijnzeel-Koomen, M.D., Ph.D.
University Medical Center Utrecht
Clinical relevance of peanut epitope recognition by IgE/IgG4 in adults
Donata Vercelli, M.D.
Arizona Board of Regents, University of Arizona
Impact of genetic factors on the natural history of food sensitization
2006 Cycle
Ke Zhang, M.D., Ph.D.
Regents of the University of California, Los Angeles
IgE-directed DNA vaccination for food (peanut) allergy immunotherapy
Marc Rothenberg, M.D., Ph.D.
Cincinnati Children's Hospital Medical Center
Molecular analysis of eosinophilic esophagitis
Randall Kopper, Ph.D.
Hendrix College
Reduction of peanut anaphylaxis by treatment with activated charcoal
Simon Brown, Ph.D.
University of Western Australia
Mediators of human anaphylaxis
2005 Cycle
Kirsten Beyer, M.D.
Charité Universitätsmedizin Berlin
Treatment of peanut allergy through specific oral tolerance induction
David Broide, M.B., Ch.B.
University of California, San Diego
Anti-Siglec F: A novel therapy for food allergy
Stephen Dreskin, M.D., Ph.D.
University of Colorado at Denver and Health Sciences Center
Peanut allergy: HLA and environment
Gideon Lack, M.D.
King’s College
In vitro evidence for cutaneous sensitization in peanut allergy
2004 Cycle
Wesley Burks, M.D.
Duke University
Oral peanut immunotherapy
Wyatt Decker, M.D.
Mayo Clinic
The epidemiology and prehospital care of anaphylaxis in Olmsted County, MN
(Special Strategic Initiatives Grant)
Fred Finkelman, M.D.
University of Cincinnati Medical Center
Pathophysiology of local and systemic food allergy in a mouse model
Chris Kepley, Ph.D.
Virginia Commonwealth University
Development of a peanut allergy model system to test therapeutic compounds
Marc E. Rothenberg, M.D., Ph.D.
Cincinnati Children’s Hospital Medical Center
Epidemiology and molecular classification of eosinophilic esophagitis (EE)
Research Grant Recipients
|
Program Update
|
||
2009
Carlos Camargo, M.D., Dr.P.H.
Massachusetts General Hospital
Prospective study of vitamin D in cord blood and risk of food allergy
Simon Hogan, Ph.D.
Cincinnati Children's Hospital Medical Center
Intestinal IL-9 and mast cells in food-induced anaphylaxis
Patrick Leung, Ph.D.
University of California-Davis
Mimotype vaccine against shrimp tropomyosin
Marc Rothenberg, M.D., Ph.D.
Cincinnati Children's Hospital Medical Center
The role of CREB binding protein (CBP) in eosinophilic esophagitis (EE)
Xiaoping Zhong, M.D., Ph.D.
Duke University Medical Center
Therapy for peanut-induced allergy and anaphylaxis
Daocheng Zhu, M.D., Ph.D.
Northwestern University - Evanston
Novel plant-human fusion proteins block peanut allergy
2008
Kirsten Beyer, M.D.
Charité Universitätsmedizin Berlin
Primary prevention of hen’s egg allergy through early hen’s egg feeding
Mimi Tang, Ph.D.
Murdoch Childrens Research Institute
Probiotics and oral immunotherapy for the treatment of peanut allergy
Carla Bruijnzeel-Koomen, M.D., Ph.D.
University Medical Center Utrecht
Clinical relevance of peanut epitope recognition by IgE/IgG4 in adults
Donata Vercelli, M.D.
Arizona Board of Regents, University of Arizona
Impact of genetic factors on the natural history of food sensitization
2007
Ke Zhang, M.D., Ph.D.
Regents of the University of California, Los Angeles
IgE-directed DNA vaccination for food (peanut) allergy immunotherapy
Marc Rothenberg, M.D., Ph.D.
Cincinnati Children's Hospital Medical Center
Molecular analysis of eosinophilic esophagitis
Randall Kopper, Ph.D.
Hendrix College
Reduction of peanut anaphylaxis by treatment with activated charcoal
Simon Brown, Ph.D.
University of Western Australia
Mediators of human anaphylaxis
2006
Kirsten Beyer, M.D.
Charité Universitätsmedizin Berlin
Treatment of peanut allergy through specific oral tolerance induction
David Broide, M.B., Ch.B.
University of California, San Diego
Anti-Siglec F: A novel therapy for food allergy
Stephen Dreskin, M.D., Ph.D.
University of Colorado at Denver and Health Sciences Center
Peanut allergy: HLA and environment
Gideon Lack, M.D.
King’s College
In vitro evidence for cutaneous sensitization in peanut allergy
2005
Wesley Burks, M.D.
Duke University
Oral peanut immunotherapy
Wyatt Decker, M.D.
Mayo Clinic
The epidemiology and prehospital care of anaphylaxis in Olmsted County, MN
(Special Strategic Initiatives Grant)
Fred Finkelman, M.D.
University of Cincinnati Medical Center
Pathophysiology of local and systemic food allergy in a mouse model
Chris Kepley, Ph.D.
Virginia Commonwealth University
Development of a peanut allergy model system to test therapeutic compounds
Marc E. Rothenberg, M.D., Ph.D.
Cincinnati Children’s Hospital Medical Center
Epidemiology and molecular classification of eosinophilic esophagitis (EE)



Connect With Us